Working… Menu
Trial record 1 of 1 for:    upadacitinib | GCa
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03725202
Recruitment Status : Recruiting
First Posted : October 30, 2018
Last Update Posted : March 9, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 30, 2023
Estimated Study Completion Date : November 25, 2024